Viewing Study NCT00632268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-02 @ 1:42 PM
Study NCT ID: NCT00632268
Status: COMPLETED
Last Update Posted: 2013-08-21
First Post: 2008-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Sponsor: National Taiwan University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mTOR inhibitor View
None RAD001 View
None everolimus View
None chemotherapy View
None cisplatin View
None high-dose 5-FU View